K
47
2
HCP
33
2
VIX
71
-3
RSG
73
3
TAP
47
2
XYL
43
-6
KLAC
57
-4
HAL
50
-3
AN
50
3
EW
40
-4
WHR
32
-3
HCA
39
2
MCD
55
5
CCL
30
4
GME
52
2
DGX
36
-3
SLG
71
5
SPG
46
-2
GILD
28
-2
SLB
45
-3
K
47
2
HCP
33
2
VIX
71
-3
RSG
73
3
TAP
47
2
XYL
43
-6
KLAC
57
-4
HAL
50
-3
AN
50
3
EW
40
-4
WHR
32
-3
HCA
39
2
MCD
55
5
CCL
30
4
GME
52
2
DGX
36
-3
SLG
71
5
SPG
46
-2
GILD
28
-2
SLB
45
-3
Financhill
Back

P3 Health Partners 10K Form

Sell
13

PIII
P3 Health Partners

Last Price:
0.50
Seasonality Move:
61.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PIII News And Ratings

See the #1 stock for the next 7 days that we like better than PIII

PIII Financial Statistics

Sales & Book Value

Annual Sales: $1.27B
Cash Flow: $-15.67M
Price / Cash Flow: 0
Annual Sales: $1.22
Price / Book: 0.42

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-57.77M
Gross Margin: --
Return on Equity: -12.43%
Return on Assets: -6.55%

P3 Health Partners Earnings Forecast

Key P3 Health Partners Financial Ratios

  • The Interest Expense is -27.67% of Operating Income.
  • The Net Earning history of PIII is -4.56% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

P3 Health Partners Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: PIII
Website: p3hp.org

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 0.55
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PIII Technical Analysis vs Fundamental Analysis

Sell
13
P3 Health Partners (PIII) is a Sell

Is P3 Health Partners a Buy or a Sell?